Article citationsMore>>

Waghorne, C.L., Corkran, H.M., Hunt-Painter, A.A., Niktab, E., Baty, J.W., Berridge, M.V., Munkacsi, A.B., McConnell, M.J., Timmer, M.S.M. and Stocker, B.L. (2016) N,N-Bis(gly- cityl)amines as Anti-Cancer Drugs. Bioorganic and Medicinal Chemistry, 24, 3932-3939.
https://doi.org/10.1016/j.bmc.2016.04.016

has been cited by the following article:

• TITLE: Biological Evaluation of New Schiff Bases: Synthesized from 4-Amino-3,5-dimethyl-1,2,4-triazole, Phenathroline and Bipyridine Dicarboxaldehydes

  AUTHORS: Md. Shafiqul Islam, Mohammad R. Karim, William Boadi, Seyi Falekun, Aminul H. Mirza

  KEYWORDS: [2, 2’-Bipyridine]-5, 5’-dicarboxaldehyde, Schiff Bases, Anticancer, Glutathione, Anti-Bacterial

  JOURNAL NAME: Advances in Biological Chemistry, Vol.6 No.6, December 29, 2016

  ABSTRACT: Four new Schiff bases with promising anticancer activity have been synthesized from 4-amino-3,5-dimethyl-1,2,4-triazole and di-pyridyl-aldehydes. Structures have been established by various spectroscopic methods. The compounds were tested in vitro to study their cytotoxicity and anti-oxidative activity in human lung carcinoma (A549), breast carcinoma (BT549), prostate adenocarcinoma (PC3) and mouse preadipocytes (3T3-L1) cells. Compound 1 was found to increase Glutathione (GSH) level slightly in all four cell lines. Compound 4 showed better selectivity and cytotoxicity against both BT549 and A549 cells compared to the anticancer drug tamoxifen. With the exception of compound 4 which reduced GSH levels in A549 and BT549, all other compounds maintained GSH levels in comparison to their respective controls.